Yüklüyor......
Review of Bone Modifying Agents in Metastatic Breast Cancer
Bone is the most common site for distant metastases in breast cancer and can cause significant morbidity and mortality. Bone modifying agents (BMAs) that include bisphosphonates (BPAs) and denosumab help in decreasing and delaying skeletal-related events (SREs) associated with metastatic breast canc...
Kaydedildi:
| Yayımlandı: | Cureus |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Cureus
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7960030/ https://ncbi.nlm.nih.gov/pubmed/33738175 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.13332 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|